BioAmp is working to counteract antibiotic resistance through the development of precision diagnostics, empowering physicians.
BioAmp is working to counteract antibiotic resistance through the development of precision diagnostics, empowering physicians around the world with the information they need to treat their patients with the right antibiotic the first time.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 27, 2020 | Grant | $224.99K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |